Position in ANIP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$910,496
New position
Shares Held
11,840
first reported quarter
Ownership
0.052%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Diametric Capital, LP holds $18,670,747 across 10 Drug Manufacturers - Specialty & Generic names. ANIP ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
167,760 | $6,331,262 | |
| 2 | HROW |
Harrow, Inc.
|
110,698 | $3,903,211 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
156,926 | $3,872,933 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
|
335,443 | $1,392,088 | |
| 5 | DERM |
Journey Medical Corp
|
196,412 | $921,172 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
This page
|
11,840 | $910,496 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
17,900 | $428,347 | |
| 8 | LFCR |
Lifecore Biomedical, Inc. \De\
|
105,149 | $391,154 |
All Filings in ANIP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $910,496 | 11,840 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||